Transcriptional Dysregulation in Down Syndrome: Predictions for Altered Protein Complex Stoichiometries and Post-translational Modifications, and Consequences for Learning/Behavior Genes ELK, CREB, and the Estrogen and Glucocorticoid Receptors

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Behavior Genetics

• Publication date

  2006-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S10519-006-9051-1PMID 16502135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Walking patterns in Down's syndrome.

  2008cited by this paper
• Measurements of neuromuscular tone and strength in Down's syndrome children.

  2008cited by this paper
• Mouse models of Down syndrome

  2005cited by this paper
• Dephosphorylated C/EBPα Accelerates Cell Proliferation through Sequestering Retinoblastoma Protein

  2005cited by this paper
• ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons

  2005cited by this paper
• The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome.

  2005cited by this paper
• Systematic Identification and Analysis of Mammalian Small Ubiquitin-like Modifier Substrates*

  2005cited by this paper
• Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition.

  2004cited by this paper
• Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome.

  2004cited by this paper
• Essential Requirement of CCAAT/Enhancer Binding Proteins in Embryogenesis

  2004cited by this paper
• Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome.

  2004cited by this paper
• Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

  2004cited by this paper
• Transcriptional mechanisms of hippocampal aging.

  2004cited by this paper
• Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes.

  2004cited by this paper
• MAPK cascade signalling and synaptic plasticity

  2004cited by this paper
• Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes

  2004cited by this paper
• Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

  2004cited by this paper
• Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome

  2004cited by this paper
• Transgenic Mouse In Vivo Library of Human Down Syndrome Critical Region 1: Association between DYRK1A Overexpression, Brain Development Abnormalities, and Cell Cycle Protein Alteration

  2004cited by this paper
• Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.

  2004cited by this paper
• Building protein interaction maps for Down's syndrome.

  2004cited by this paper
• Ternary Complex Factor-Serum Response Factor Complex-Regulated Gene Activity Is Required for Cellular Proliferation and Inhibition of Apoptotic Cell Death

  2004cited by this paper
• A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes

  2004cited by this paper
• Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS.

  2004cited by this paper
• Dyrk1A Potentiates Steroid Hormone-Induced Transcription via the Chromatin Remodeling Factor Arip4

  2004cited by this paper
• Tissue-specific overexpression of the HSA21 gene GABPα: implications for DS

  2004cited by this paper
• Impact of Estrogen Therapy on Alzheimer’s Disease

  2004cited by this paper
• Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.

  2004cited by this paper
• A M55V Polymorphism in a Novel SUMO Gene (SUMO-4) Differentially Activates Heat Shock Transcription Factors and Is Associated with Susceptibility to Type I Diabetes Mellitus*

  2004cited by this paper
• Calcineurin in animal behavior.

  2004cited by this paper
• GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.

  2004cited by this paper
• SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1

  2004cited by this paper
• The role of hippocampal signaling cascades in consolidation of fear memory.

  2004cited by this paper
• Gene-dosage effects in Down syndrome and trisomic mouse models

  2004cited by this paper
• Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.

  2003cited by this paper
• The role of modulatory calcineurin-interacting proteins in calcineurin signaling.

  2003cited by this paper
• Molecular changes in fetal Down syndrome brain

  2003cited by this paper
• Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions.

  2003cited by this paper
• The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: Implications for mental retardation

  2003cited by this paper
• Calcineurin controls the expression of numerous genes in cerebellar granule cells.

  2003cited by this paper
• Modification of CCAAT/Enhancer-binding Protein-β by the Small Ubiquitin-like Modifier (SUMO) Family Members, SUMO-2 and SUMO-3*

  2003cited by this paper
• Brain-Derived Neurotrophic Factor Activation of NFAT (Nuclear Factor of Activated T-Cells)-Dependent Transcription: A Role for the Transcription Factor NFATc4 in Neurotrophin-Mediated Gene Expression

  2003cited by this paper
• Genetics of childhood disorders: LII. Learning and memory, part 5: human cognitive disorders and the ras/ERK/CREB pathway.

  2003cited by this paper
• Intersectin Activates Ras but Stimulates Transcription through an Independent Pathway Involving JNK*

  2003cited by this paper
• Nuclear and unclear functions of SUMO

  2003cited by this paper
• Calcineurin in memory and bidirectional plasticity.

  2003cited by this paper
• Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain.

  2003cited by this paper
• Calcineurin regulation of neuronal plasticity.

  2003cited by this paper
• Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy

  2003cited by this paper
• Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome

  2003cited by this paper
• App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome

  2003cited by this paper
• The neuropsychology of Down syndrome: evidence for hippocampal dysfunction.

  2003cited by this paper
• Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.

  2003cited by this paper
• Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.

  2003cited by this paper
• The MNB/DYRK1A protein kinase: genetic and biochemical properties.

  2003cited by this paper
• Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity.

  2003cited by this paper
• A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3*

  2003cited by this paper
• Positive and negative regulation of APP amyloidogenesis by sumoylation

  2002cited by this paper
• Corticosteroid receptors in the brain: gene targeting studies.

  2002cited by this paper
• Estrogens and neuroprotection.

  2002cited by this paper
• The Nuclear Receptor Interaction Domain of GRIP1 Is Modulated by Covalent Attachment of SUMO-1*

  2002cited by this paper
• Function and regulation of CREB family transcription factors in the nervous system.

  2002cited by this paper
• Estrogen actions throughout the brain.

  2002cited by this paper
• Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1*

  2002cited by this paper
• Synergistic activation of the human choline acetyltransferase gene by c-Myb and C/EBPbeta.

  2002cited by this paper
• Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.

  2002cited by this paper
• Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders.

  2002cited by this paper
• Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.

  2002cited by this paper
• The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium‐mediated stress damage, including transient oxidative stress

  2002cited by this paper
• Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.

  2002cited by this paper
• Protective Effects of Estrogen and Selective Estrogen Receptor Modulators in the Brain1

  2002cited by this paper
• Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function.

  2001cited by this paper
• Calcium regulation of neuronal gene expression

  2001cited by this paper
• Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory

  2001cited by this paper
• Animal Cytogenetics and Comparative Mapping

  2001cited by this paper
• The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory

  2001cited by this paper
• Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia.

  2001cited by this paper
• Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges.

  2001cited by this paper
• The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.

  2001cited by this paper
• Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.

  2001cited by this paper
• Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion

  2001cited by this paper
• Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells.

  2001cited by this paper
• Protein Kinase Dyrk1 Activates cAMP Response Element-binding Protein during Neuronal Differentiation in Hippocampal Progenitor Cells*

  2001cited by this paper
• Opposing Roles of Elk-1 and Its Brain-specific Isoform, Short Elk-1, in Nerve Growth Factor-induced PC12 Differentiation*

  2001cited by this paper
• Down syndrome and Alzheimer's disease: a link between development and aging.

  2001cited by this paper
• Accessory factors in clathrin-dependent synaptic vesicle endocytosis

  2000cited by this paper
• Down Syndrome: Neuropsychology and Animal Models

  2000cited by this paper
• Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3*

  2000cited by this paper
• Ets target genes: past, present and future

  2000cited by this paper
• Mouse Models in the Study of Genetic Neurological Disorders

  1999cited by this paper
• An intronic enhancer containing an N-box motif is required for synapse- and tissue-specific expression of the acetylcholinesterase gene in skeletal muscle fibers.

  1999cited by this paper
• In Vivo Expression and Regulation of Elk-1, a Target of the Extracellular-Regulated Kinase Signaling Pathway, in the Adult Rat Brain

  1998cited by this paper
• Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome.

  1998cited by this paper
• Identification of a signaling pathway involved in calcium regulation of BDNF expression.

  1998cited by this paper
• SMT3A, a human homologue of the S. cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family.

  1997cited by this paper
• Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome

  1997cited by this paper
• Regulated Membrane Localization of Tiam1, Mediated by the NH2-terminal Pleckstrin Homology Domain, Is Required for Rac-dependent Membrane Ruffling and C-Jun NH2-terminal Kinase Activation

  1997cited by this paper
• Camstatins Are Peptide Antagonists of Calmodulin Based Upon a Conserved Structural Motif in PEP-19, Neurogranin, and Neuromodulin*

  1996cited by this paper
• Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

  1996cited by this paper
• Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

  1995cited by this paper

• Single-Nucleus Profiling Identifies Accelerated Oligodendrocyte Precursor Cell Senescence in a Mouse Model of Down Syndrome

  2023cites this paper
• Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy.

  2022cites this paper
• Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model

  2021cites this paper
• RIP140 in Stress Response of the Brain

  2020cites this paper
• Ubiquitin and Ubiquitin-Like Proteins in the Critical Equilibrium between Synapse Physiology and Intellectual Disability

  2020cites this paper
• Cognitive impairments in adult mice with RIP140 overexpression in neural stem cells.

  2020cites this paper
• Down syndrome: Neurobiological alterations and therapeutic targets

  2019cites this paper
• Differentially expressed gene (DEG) based protein-protein interaction (PPI) network identifies a spectrum of gene interactome, transcriptome and correlated miRNA in nondisjunction Down syndrome.

  2019cites this paper
• Analysis of Human Nuclear Protein Complexes by Quantitative Mass Spectrometry Profiling

  2018cites this paper
• Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets

  2018cites this paper
• Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome

  2017cites this paper
• Maternal Chronic Folate Supplementation Ameliorates Behavior Disorders Induced by Prenatal High-Fat Diet Through Methylation Alteration of BDNF and Grin2b in Offspring Hippocampus.

  2017cites this paper
• Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells

  2017cites this paper
• Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.

  2017cites this paper
• Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome

  2017cites this paper
• Physical activity and bone mineral density at the femoral neck subregions in adolescents with Down syndrome

  2017cites this paper
• Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder

  2017cites this paper
• Etude du rôle du corégulateur transcriptionnel RIP140 dans le contrôle de l'instabilité microsatellitaire des cancers colorectaux héréditaires

  2017cites this paper
• Nrf2 and rip140 as new therapeutic targets for x-linked adrenoleukodystrophy (x-ald): control of redox/metabolic homeostasis and inflammation

  2017cites this paper
• Analysis of Protein SUMOylation and SUMO Pathway Enzyme Levels in Alzheimer’s Disease and Down’s Syndrome

  2017cites this paper
• Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia

  2016cites this paper
• Ouder worden met trisomie 21

  2016cites this paper
• Sumoylation in Synaptic Function and Dysfunction

  2016cites this paper
• Nuclear AgNOR protein enhancement in nucleoplasms of peripheral blood lymphocytes of babies/children with down syndrome

  2016cites this paper
• Differentially expressed miRNAs in trisomy 21 placentas

  2016cites this paper
• Evolution of myeloid leukemia in children with Down syndrome

  2016cites this paper
• Role of extracellular matrix and mitochondria related genes in determining cardiac defects in Down syndrome

  2015cites this paper
• HSA21 Single-Minded 2 (Sim2) Binding Sites Co-Localize with Super-Enhancers and Pioneer Transcription Factors in Pluripotent Mouse ES Cells

  2015cites this paper
• Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models

  2015cites this paper
• Luciano Gaudio A regulatory crosstalk in Down syndrome : competing mRNA-miRNA network

  2015cites this paper
• Changes in nuclear receptor corepressor RIP140 do not influence mitochondrial content in the cortex.

  2015cites this paper
• NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome.

  2014cites this paper
• Receptor interacting protein 140 attenuates endoplasmic reticulum stress in neurons and protects against cell death

  2014cites this paper
• The bone tissue of children and adolescents with Down syndrome is sensitive to mechanical stress in certain skeletal locations: a 1-year physical training program study.

  2014cites this paper
• Emotional regulatory function of receptor interacting protein 140 revealed in the ventromedial hypothalamus.

  2014influential citation
• Investigation of the molecular mechanisms underlying Down syndrome phenotypes

  2013cites this paper
• Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects.

  2013cites this paper
• Molecular alteratons leading to mitochondrial dysfunction in Down Syndrome

  2013cites this paper
• Massively Parallel Sequencing Reveals the Complex Structure of an Irradiated Human Chromosome on a Mouse Background in the Tc1 Model of Down Syndrome

  2013cites this paper
• Correlation of increased hippocampal Sumo3 with spatial learning ability in old C57BL/6 mice.

  2012cites this paper
• Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

  2012cites this paper
• Original Article Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells

  2012cites this paper
• Cognitive impairments in adult mice with constitutive inactivation of RIP140 gene expression

  2012cites this paper
• Peroxisome proliferator‐activated receptor‐γ cofactors in neurodegeneration

  2012cites this paper
• Genomic determinants in the phenotypic variability of Down syndrome.

  2012cites this paper
• Host genetic effects on HIV-1 replication in macrophages

  2011cites this paper
• Elk-1 a Transcription Factor with Multiple Facets in the Brain

  2011cites this paper
• Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages

  2011cites this paper
• Molecular bases of Down syndrome: differential gene expression and pathway dysregulation associated with trisomy 21

  2011cites this paper
• Putting the Brakes on Proliferation Gene Dosage Effects on Hippocampal Neurogenesis in the Ts65Dn Mouse Model of Down Syndrome

  2011cites this paper
• Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome

  2011cites this paper
• Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes

  2011cites this paper
• Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.

  2010cites this paper
• Molecular basis of pharmacotherapies for cognition in Down syndrome.

  2010cites this paper
• Age-related changes in plasma levels of BDNF in Down syndrome patients

  2010cites this paper
• The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome

  2009cites this paper
• AgNOR status in Down's syndrome infants and a plausible phenotype formation hypothesis.

  2009cites this paper
• Adolescents with Developmental Disabilities and Their Families

  2009cites this paper
• Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses

  2009influential citation
• Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK‐801

  2008cites this paper
• Nuclear protein contents in peripheral blood mononuclear cells of trisomy 21 infants

  2008cites this paper
• Possible Compensatory Events in Adult Down Syndrome Brain Prior to the Development of Alzheimer Disease Neuropathology: Targets for Nonpharmacological Intervention

  2007cites this paper
• Genetic mechanisms involved in the phenotype of Down syndrome.

  2007cites this paper
• Gene expression profiling in the adult Down syndrome brain.

  2007cites this paper
• Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes.

  2007cites this paper
• Trisomy 21: From Chromosomes to Mental Retardation

  2006cites this paper
• DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis

  2006cites this paper
• The proteins of human chromosome 21

  2006cites this paper
• Mechanisms of Depolarization Induced Dendritic Growth of Drosophila Motor Neurons

  2006cites this paper
• The nuclear receptor transcriptional coregulator RIP140

  2006cites this paper